144 related articles for article (PubMed ID: 23378343)
21. Genetic variations in epigenetic genes are predictors of recurrence in stage I or II non-small cell lung cancer patients.
Wagner KW; Ye Y; Lin J; Vaporciyan AA; Roth JA; Wu X
Clin Cancer Res; 2012 Jan; 18(2):585-92. PubMed ID: 22252258
[TBL] [Abstract][Full Text] [Related]
22. Variations within 3'-UTR of MDM4 gene contribute to clinical outcomes of advanced non-small cell lung cancer patients following platinum-based chemotherapy.
Yang Y; Gao W; Ding X; Xu W; Liu D; Su B; Sun Y
Oncotarget; 2017 Mar; 8(10):16313-16324. PubMed ID: 27462918
[TBL] [Abstract][Full Text] [Related]
23. Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk.
Xie K; Wang C; Qin N; Yang J; Zhu M; Dai J; Jin G; Shen H; Ma H; Hu Z
Oncotarget; 2016 Jul; 7(30):47966-47974. PubMed ID: 27374108
[TBL] [Abstract][Full Text] [Related]
24. Genetic Polymorphisms in Activating Transcription Factor 3 Binding Site and the Prognosis of Early-Stage Non-Small Cell Lung Cancer.
Kang HG; Park JE; Lee SY; Choi JE; Do SK; Hong MJ; Lee JH; Jeong JY; Do YW; Lee EB; Shin KM; Lee WK; Choi SH; Lee YH; Seo HW; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
Oncology; 2021; 99(5):336-344. PubMed ID: 33626541
[TBL] [Abstract][Full Text] [Related]
25. Variant SNPs at the microRNA complementary site in the B7‑H1 3'‑untranslated region increase the risk of non‑small cell lung cancer.
Du W; Zhu J; Chen Y; Zeng Y; Shen D; Zhang N; Ning W; Liu Z; Huang JA
Mol Med Rep; 2017 Sep; 16(3):2682-2690. PubMed ID: 28677815
[TBL] [Abstract][Full Text] [Related]
26. Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival.
Yang S; Tang D; Zhao YC; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Shen S; Christiani DC; Wang Q; Wei Q
Int J Cancer; 2020 Jul; 147(2):392-403. PubMed ID: 31618441
[TBL] [Abstract][Full Text] [Related]
27. Association of CASP7 polymorphisms and survival of patients with non-small cell lung cancer with platinum-based chemotherapy treatment.
Qian J; Gu S; Wu Q; Zhao X; Wu W; Gao Z; Zhang W; Tan X; Wang H; Wang J; Fan W; Chen H; Han B; Lu D; Wei Q; Jin L
Chest; 2012 Sep; 142(3):680-689. PubMed ID: 22441531
[TBL] [Abstract][Full Text] [Related]
28. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
Xu TP; Shen H; Liu LX; Shu YQ
Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese.
Ma H; Shu Y; Pan S; Chen J; Dai J; Jin G; Hu Z; Shen H
Lung Cancer; 2011 Nov; 74(2):164-9. PubMed ID: 21514686
[TBL] [Abstract][Full Text] [Related]
30. MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer.
Li R; Pu X; Chang JY; Ye Y; Komaki R; Minna JD; Roth JA; Han B; Wu X
PLoS One; 2016; 11(3):e0150467. PubMed ID: 26991123
[TBL] [Abstract][Full Text] [Related]
31. DNA Repair Gene Polymorphisms in Relation to Non-Small Cell Lung Cancer Survival.
Su Y; Zhang H; Xu F; Kong J; Yu H; Qian B
Cell Physiol Biochem; 2015; 36(4):1419-29. PubMed ID: 26159902
[TBL] [Abstract][Full Text] [Related]
32. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma.
Lin J; Horikawa Y; Tamboli P; Clague J; Wood CG; Wu X
Carcinogenesis; 2010 Oct; 31(10):1805-12. PubMed ID: 20732906
[TBL] [Abstract][Full Text] [Related]
33. Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer.
Lin M; Stewart DJ; Spitz MR; Hildebrandt MA; Lu C; Lin J; Gu J; Huang M; Lippman SM; Wu X
Carcinogenesis; 2011 Jul; 32(7):1050-6. PubMed ID: 21515830
[TBL] [Abstract][Full Text] [Related]
34. Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer.
Yin J; Lu C; Gu J; Lippman SM; Hildebrandt MA; Lin J; Stewart D; Spitz MR; Wu X
Carcinogenesis; 2011 Dec; 32(12):1867-71. PubMed ID: 21965272
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
[TBL] [Abstract][Full Text] [Related]
36. The single nucleotide variant rs2868371 associates with the risk of mortality in non-small cell lung cancer patients: A multicenter prospective validation.
Enguix-Riego MDV; Cacicedo J; Delgado León BD; Nieto-Guerrero Gómez JM; Herrero Rivera D; Perez M; Praena-Fernández JM; Sanchez Carmona G; Rivin Del Campo E; Ortiz Gordillo MJ; Lopez Guerra JL
Radiother Oncol; 2019 Jul; 136():29-36. PubMed ID: 31015126
[TBL] [Abstract][Full Text] [Related]
37. TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy.
Guan X; Liao Z; Ma H; Qian J; Liu Z; Yuan X; Gomez D; Komaki R; Wang LE; Wei Q
BMC Cancer; 2011 Oct; 11():447. PubMed ID: 21995493
[TBL] [Abstract][Full Text] [Related]
38. Association of miRNA-related genetic polymorphisms and prognosis in patients with esophageal squamous cell carcinoma.
Yang PW; Huang YC; Hsieh CY; Hua KT; Huang YT; Chiang TH; Chen JS; Huang PM; Hsu HH; Kuo SW; Kuo ML; Lee JM
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S601-9. PubMed ID: 24770678
[TBL] [Abstract][Full Text] [Related]
39. HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer.
Xu T; Wei Q; Lopez Guerra JL; Wang LE; Liu Z; Gomez D; O'Reilly M; Lin SH; Zhuang Y; Levy LB; Mohan R; Zhou H; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e229-35. PubMed ID: 22608953
[TBL] [Abstract][Full Text] [Related]
40. A functional variant in miR-155 regulation region contributes to lung cancer risk and survival.
Xie K; Ma H; Liang C; Wang C; Qin N; Shen W; Gu Y; Yan C; Zhang K; Dai N; Zhu M; Wu S; Wang H; Dai J; Jin G; Shen H; Hu Z
Oncotarget; 2015 Dec; 6(40):42781-92. PubMed ID: 26543233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
